Repository logo
 

A comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status

cam.issuedOnline2017-07-06
dc.contributor.authorFitzgerald, R
dc.contributor.authorTischkowitz, M
dc.contributor.authorDi Pietro, M
dc.contributor.authorO'Donovan, M
dc.contributor.authorRichardson, S
dc.contributor.authorMi, EM
dc.contributor.authorMi, E
dc.contributor.authorHardwick, R
dc.contributor.authorZiauddeen, H
dc.contributor.authorFletcher, PC
dc.contributor.authorCaldas, C
dc.contributor.authorRagunath, K
dc.contributor.orcidFitzgerald, Rebecca [0000-0002-3434-3568]
dc.contributor.orcidTischkowitz, Marc [0000-0002-7880-0628]
dc.contributor.orcidDi Pietro, Massimiliano [0000-0003-4866-7026]
dc.contributor.orcidZiauddeen, Hisham [0000-0003-4044-1719]
dc.contributor.orcidFletcher, Paul [0000-0001-8257-1517]
dc.contributor.orcidCaldas, Carlos [0000-0003-3547-1489]
dc.date.accessioned2017-07-20T13:49:35Z
dc.date.available2017-07-20T13:49:35Z
dc.date.issued2017-07-06
dc.description.abstractBackground and aims Hereditary Diffuse Gastric Cancer (HDGC) accounts for 1% of gastric cancer cases. For patients with a germline CDH1 mutation, risk-reducing gastrectomy is recommended. However, for those delaying surgery or families with no causative mutation identified, regular endoscopy is advised. This study aimed to determine the yield of signet ring cell carcinoma (SRCC) foci in individuals with a CDH1 pathogenic variant compared to those without and how this varies with successive endoscopies. Methods Patients fulfilling HDGC criteria were recruited to a prospective longitudinal cohort study. Endoscopy was performed according to a strict protocol with visual inspection followed by focal lesion and random biopsies, to detect foci of SRCC. Survival analysis determined progression to finding of SRCC according to CDH1 mutation status. EORTC-QLQ-C30 and SF-36 questionnaires assessed quality-of-life at pre-surveillance and each endoscopy. Results 85 individuals fulfilling HDGC criteria underwent 201 endoscopies. 54 (63.5%) tested positive for CDH1 mutation. SRCC yield was 61.1% in CDH1 mutation carriers compared to 9.7% in non-carriers, and mutation positive patients had a 10-fold risk of SRCC on endoscopy compared to those with no mutation detected (p<0.0005). Yield of SRCC decreased substantially with subsequent endoscopies. Surveillance was associated with improved psychological health. Conclusions SRCC foci are prevalent in CDH1 mutation carriers and can be detected at endoscopy using a standardised, multiple biopsy protocol. Decreasing yield over time suggests that the frequency of endoscopy might be reduced. For patients with no CDH1 pathogenic variant detected, the cost:benefit ratio needs to be assessed in view of the low yield.
dc.identifier.doi10.17863/CAM.11352
dc.identifier.eissn1097-6779
dc.identifier.issn0016-5107
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/265683
dc.language.isoeng
dc.publisherElsevier
dc.publisher.urlhttp://dx.doi.org/10.1016/j.gie.2017.06.028
dc.rightsAttribution 4.0 International
dc.rightsAttribution 4.0 International
dc.rightsAttribution 4.0 International
dc.rightsAttribution 4.0 International
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAdult
dc.subjectAntigens, CD
dc.subjectBiopsy
dc.subjectCadherins
dc.subjectCarcinoma, Signet Ring Cell
dc.subjectEarly Detection of Cancer
dc.subjectFemale
dc.subjectGastric Mucosa
dc.subjectGastroscopy
dc.subjectGerm-Line Mutation
dc.subjectHumans
dc.subjectLongitudinal Studies
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPopulation Surveillance
dc.subjectProspective Studies
dc.subjectQuality of Life
dc.subjectStomach Neoplasms
dc.subjectTime Factors
dc.titleA comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status
dc.typeArticle
dcterms.dateAccepted2017-06-29
prism.publicationDate2017
prism.publicationNameGastrointestinal Endoscopy
pubs.funder-project-idEuropean Research Council (310018)
pubs.funder-project-idMRC (unknown)
pubs.funder-project-idMedical Research Council (MC_UU_12022/2)
rioxxterms.licenseref.startdate2017-07-06
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/
rioxxterms.typeJournal Article/Review
rioxxterms.versionAM
rioxxterms.versionofrecord10.1016/j.gie.2017.06.028

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Accepted manuscript.docx
Size:
4.04 MB
Format:
Microsoft Word XML
Description:
Accepted version
Licence
http://creativecommons.org/licenses/by/4.0/
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
DepositLicenceAgreement.pdf
Size:
417.78 KB
Format:
Adobe Portable Document Format